NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-494-2013-0-IT-33 Methods of Preparing Anti-human Papillomavirus Antigen T Cells IT EP 19209253.4 Issued
NIAID E-120-2001-1-US-01 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 16/684,103 11318196 Expired PDF
NCI E-040-2012-0-US-40 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,524 10900042 Issued PDF
NCI E-040-2012-0-US-41 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,543 10876123 Issued PDF
NCI E-040-2012-0-US-38 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,477 10844387 Issued PDF
NCI E-040-2012-0-US-39 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,494 10829767 Issued PDF
NCI E-040-2012-0-US-42 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,625 10815488 Issued PDF
NCI E-040-2012-0-US-35 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,417 10815487 Issued PDF
NCI E-040-2012-0-US-37 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,453 10738313 Issued PDF
NCI E-040-2012-0-US-36 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,435 10738312 Issued PDF
NCI E-175-2016-0-HK-13 ANTI-KRAS-G12D T CELL RECEPTORS HK CN 19132196.7 Pending
CC E-158-2017-0-US-03 SYSTEMS, METHODS, AND DEVICES FOR ASSISTING OR PERFORMING GUIDED INTERVENTIONAL PROCEDURES USING INERTIAL MEASUREMENT UNITS AND MAGNETOMETER SENSORS US National Stage 16/613,591 Pending
NIBIB E-150-2016-1-US-06 Evans Blue Attachment Enhances Somatostatin Receptor Imaging And Radiotherapy US National Stage 16/613,196 10981866 Issued PDF
NCI E-007-2019-0-PCT-02 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER PCT PCT PCT/US2019/061251 Expired
NCI E-017-2017-0-US-10 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US National Stage 16/613,187 Pending
NCI E-017-2017-0-JP-07 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES JP National Stage 2019-563082 Pending
NCI E-035-2017-0-CN-07 STAT3 INHIBITOR FORMULATION CN National Stage 201880031431.0 Abandoned
NCI E-085-2013-0-EP-12 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood EP DIV 19208596.7 Pending
NCI E-127-2017-0-US-07 COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+
MALIGNANCIES 		US National Stage 16/612,495 11440963 Issued PDF
NCI E-099-2014-0-JP-10 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2019-203937 Pending
NCI E-017-2017-0-SG-09 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES SG National Stage 11201910499V Pending
NCI E-127-2017-0-JP-06 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies JP National Stage 2019-561944 Issued
NCI E-127-2017-0-AU-03 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies AU National Stage 2018266103 Pending
NCI E-494-2013-0-JP-13 Methods of Preparing Anti-human Papillomavirus Antigen T Cells JP DIV 2019-202239 Issued
NHLBI E-200-2018-0-US-03 NEW COMPOSITIONS AND METHODS FOR TREATING BETA-GLOBINOPATHIES US ORD 16/676,369 11325978 Issued PDF
NHLBI E-200-2018-0-PCT-02 Treatment Of The Beta-globinopathies Through Inhibition Of RIOK3 Activity PCT PCT PCT/US2019/060151 Expired
NCI E-069-2017-0-US-03 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL US National Stage 16/611,098 11401544 Issued PDF
NCI E-264-2011-0-EP-10 Delivery Of Packaged RNA To Mammalian Cells EP DIV 19207297.3 Pending
NCI E-017-2017-0-AU-03 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES AU National Stage 2018269194 Pending
NCI E-019-2014-2-US-03 COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT US CON 16/664,523 11692010 Issued PDF
NCATS E-198-2016-0-US-04 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling US National Stage 16/608,489 11026947 Issued PDF
NCATS E-051-2020-0-PCT-02 Crystal Forms Of An ALK2 Inhibitor PCT PCT PCT/US2019/058062 Expired
NCI E-344-2013-0-AU-01 TEM8 Antibodies and Their Use AU DIV 2022200117 Issued
NCI E-344-2013-0-AU-17 TEM8 Antibodies and Their Use AU DIV 2019253864 Issued
NCI E-166-2018-0-PCT-02 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS PCT PCT PCT/US2019/057833 Expired
NCI E-166-2018-0-US-04 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US ORD 16/662,808 Pending
NCI E-166-2018-0-TW-03 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS TW ORD 108138456 Pending
NCI E-520-2013-0-AU-09 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use AU DIV 2019203443 Issued
NCI E-520-2013-0-JP-17 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use JP DIV 2019-204306 Pending
NCI E-160-2018-0-PCT-02 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION PCT PCT PCT/US2019/057268 Expired
NIAID E-052-2017-4-US-47 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection US CON 16/659,426 Pending
NLM E-107-2010-2-US-29 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/658,195 Abandoned
NCI E-160-2018-0-EP-05 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION EP National Stage 19804901.7 Pending
NCI E-190-2014-0-JP-40 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		JP DIV 2019-191919 Abandoned
NCI E-160-2018-0-CA-04 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION CA National Stage 3117390 Pending
NCI E-160-2018-0-AU-03 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION AU National Stage 2019368218 Pending
NCI E-128-2017-0-US-04 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS US National Stage 16/606,555 11623220 Issued PDF
NIAID E-187-2018-0-PCT-02 A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS PCT PCT PCT/US2019/057038 Expired
NIAID E-216-2018-2-PCT-01 Multi-Specific Antibodies For HIV-1 And Their Utility PCT PCT COMB PCT/US2019/057089 Expired
NHGRI E-092-2014-1-US-06 SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS US DIV 16/655,004 Abandoned